LivaNova Names Anne Liddy as Chief Legal Officer
LivaNova PLC, a global medical technology company specializing in advanced therapeutic solutions, has announced the appointment of Anne Liddy as its new Chief Legal Officer, effective August 31. In this role, she will be responsible for overseeing the company’s global legal and compliance operations and will join LivaNova’s Executive Leadership Team, contributing to strategic decision-making at the highest level of the organization.
The appointment comes as LivaNova continues to strengthen its leadership structure to support ongoing innovation and long-term growth across its core cardiovascular and neuromodulation businesses. The company has been focusing on expanding its global footprint while maintaining a strong emphasis on regulatory compliance, operational excellence, and patient-centered innovation in the medical technology sector.
Anne Liddy brings more than twenty years of extensive legal and compliance experience in the healthcare and life sciences industries. Her career has been defined by advising multinational organizations on complex legal frameworks, regulatory strategy, mergers and acquisitions, intellectual property matters, commercial operations, employment law, and enterprise-wide compliance programs. This broad expertise positions her to play a central role in guiding LivaNova through an increasingly complex global regulatory environment.
Most recently, Liddy served as General Counsel at Hologic, Inc., a global leader in women’s health diagnostics, medical imaging, and surgical products. In that capacity, she led a large, international legal organization and provided strategic counsel to senior executives and the company’s Board of Directors. Her responsibilities included overseeing critical business transactions, managing regulatory compliance across multiple jurisdictions, and supporting corporate governance initiatives. She also played a key role in navigating legal considerations tied to innovation, product development, and global expansion.
During her tenure at Hologic, Liddy held a series of progressively senior roles within the company’s legal function, reflecting her growing leadership responsibilities and deepening expertise. Her oversight extended across a wide range of areas, including commercial contracting, intellectual property strategy, labor and employment matters, litigation management, and enterprise compliance programs. This experience gave her a comprehensive understanding of the legal challenges facing global medical technology companies operating in highly regulated markets.
Earlier in her career, Liddy worked at Pfizer Inc., where she served as Corporate Counsel supporting the company’s consumer healthcare division. In this role, she gained valuable experience within one of the world’s largest pharmaceutical organizations, contributing to legal and regulatory support for consumer-facing healthcare products. Her early professional development also included her time at Ropes & Gray LLP in Boston, where she began her legal career and built a foundation in corporate law within a leading law firm environment.
Commenting on the appointment, Vladimir Makatsaria, Chief Executive Officer of LivaNova, highlighted Liddy’s extensive experience and leadership capabilities. He described her as a highly accomplished executive with a proven track record of guiding organizations through complex regulatory and business environments. He emphasized that her deep understanding of healthcare law, combined with her collaborative leadership style, would be instrumental in advancing LivaNova’s strategic priorities and supporting its long-term value creation for patients, customers, and shareholders.
Makatsaria also noted that as the medical technology industry continues to evolve, companies like LivaNova must navigate an increasingly intricate landscape of regulatory requirements, global compliance standards, and innovation-driven competition. In this context, strong legal leadership is essential not only for risk management but also for enabling sustainable growth and supporting innovation pipelines that improve patient outcomes.
Anne Liddy expressed enthusiasm about joining LivaNova at what she described as a pivotal stage in the company’s development. She noted that LivaNova’s commitment to improving patient lives through innovation aligns closely with her professional values and experience. She emphasized her intention to work closely with the company’s leadership team to support strategic initiatives, strengthen its global compliance framework, and contribute to the execution of its long-term growth strategy.
She also highlighted the importance of building robust legal and compliance systems that can support innovation while ensuring adherence to global regulatory standards. As medical technology companies increasingly operate across multiple regions with varying regulatory requirements, effective legal leadership plays a critical role in enabling both agility and accountability.
Liddy’s academic background further supports her professional credentials. She holds a Bachelor of Arts degree from the College of the Holy Cross and earned her Juris Doctor from Cornell University Law School. Her education at these institutions provided a strong foundation in legal theory, analytical reasoning, and corporate law, which she has applied throughout her career in the healthcare and life sciences sectors.
LivaNova, as a global medical technology company, develops and markets innovative medical devices designed to address complex cardiovascular and neurological conditions. The company operates in a highly regulated environment where compliance, product safety, and global regulatory approvals are essential components of business success. As such, the appointment of a seasoned legal executive reflects the company’s continued emphasis on governance, regulatory excellence, and risk management.
The addition of a Chief Legal Officer with deep industry experience is expected to support LivaNova’s efforts to advance its innovation pipeline while maintaining strong oversight of legal and compliance matters across its global operations. This includes managing evolving regulatory expectations in key markets, supporting strategic partnerships and acquisitions, and ensuring that the company’s growth initiatives are aligned with legal and ethical standards.
As LivaNova continues to execute its strategic vision, the leadership transition in its legal function represents an important step in reinforcing the company’s organizational strength. With Anne Liddy joining the Executive Leadership Team, LivaNova is positioning itself to further enhance its governance capabilities while continuing to focus on delivering advanced medical technologies that improve patient outcomes worldwide.
About LivaNova
LivaNova PLC is a global medical technology company built on nearly five decades of experience and a vision to change the trajectory of lives for a new day. Through ingenious medical solutions in select neurological and cardiac conditions, LivaNova strives to ignite patient turnarounds. Headquartered in London, with approximately 3,300 employees and a presence in more than 100 countries, LivaNova serves patients, healthcare professionals, and healthcare systems worldwide.
